NKTR

Nektar Therapeutics Press Releases

$12.29
*  
0.16
1.32%
Get NKTR Alerts
*Delayed - data as of Jul. 10, 2014  -  Find a broker to begin trading NKTR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Technical Pulse on Pharma Stocks -- Research on Pfizer, Hospira, Endo Intl., and Nektar Therapeutics
7/7/2014 7:30:00 AM - PR Newswire

Data Published in the New England Journal of Medicine Demonstrate that Naloxegol Improved Opioid-Induced Constipation in Chronic Pain Patients
6/19/2014 3:29:00 PM - PR Newswire

US FDA ADVISORY COMMITTEE RECOMMENDS NO CARDIOVASCULAR OUTCOMES TRIAL FOR PERIPHERALLY-ACTING MU-OPIOID RECEPTOR ANTAGONIST (PAMORA) CLASS INCLUDING MOVANTIK
6/12/2014 4:15:00 PM - PR Newswire

Nektar Therapeutics Stock Trading Halted Today; FDA Advisory Committee to Discuss Peripherally-Acting Opioid Receptor Antagonists
6/11/2014 7:05:00 AM - PR Newswire

Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, at 50th ASCO Meeting
6/1/2014 9:00:00 AM - PR Newswire

Positive Data from Phase 2 Trial of NKTR-102 in Patients with Avastin®-Refractory High-Grade Glioma Presented at 50th ASCO Meeting
5/31/2014 2:15:00 PM - PR Newswire

Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer
5/19/2014 8:00:00 AM - PR Newswire

Nektar Therapeutics To Present at the UBS 2014 Global Healthcare Conference in New York City
5/16/2014 10:22:00 PM - PR Newswire

Technical Summary on Pharma Stocks -- Research on Salix Pharma, Nektar Therapeutics, Corcept Therapeutics, and Jazz Pharma
5/12/2014 12:30:00 PM - PR Newswire

Nektar Therapeutics Reports Financial Results for the First Quarter of 2014
5/7/2014 4:15:00 PM - PR Newswire

Nektar to Announce Financial Results for the First Quarter 2014 on Wednesday, May 7, 2014, After Close of U.S.-Based Financial Markets
5/1/2014 4:10:00 PM - PR Newswire